Skip to main content
. 2017 Feb 1;11(2):RC04–RC08. doi: 10.7860/JCDR/2017/21905.9392

[Table/Fig-3]:

Primary end point (success/failure).

At 4 week At 12 week
Success Failure Success Failure
Steroid group (n=47) 32 (68.09%) 15 (31.91%) 28 (59.57%) 19 (40.43%)
Saline group (n=46) 8 (17.39%) 38 (82.61%) 22 (47.83%) 24 (52.17%)
Intergroup difference 50.69% - 11.75% -
95% CI for the difference 33.44 to 67.94 - -8.38 to31.88 -
Number needed to treat/harm 2 9 -
p-value 0.00 - 0.25 -